EFPIA - NEWSLETTER

EFPIA Newsletter 08 October 2026

Blogs

08 October 2026 From approval to access: Why uptake of new cancer medicines still varies across Europe (Guest...

Scientific breakthroughs and regulatory approvals are critical milestones in cancer care, but they are not the end of...

Events

13 OCT 2026

Screening & Early Detection: Best Practices for National Implementation of Europe’s... Online

The EFPIA Oncology Platform (EOP) and Lung Cancer Europe are hosting the first webinar in the EOP three-part series...

Learn more →

14 OCT 2026

From medicines shortages to medicines security: Building a more resilient European... Brussels, Belgium

Bringing together stakeholders from across the healthcare value chain, this HCI event will explore how Europe can strengthen...

Learn more →

15 OCT 2026

From EU ambition to national action: Strengthening Cardiovascular Health Plans across... Brussels, Belgium

Organised by the EFPIA Cardiovascular Health Platform and IPHA, this event will explore how the EU Safe Hearts Plan...

Learn more →

What we are reading

Can paediatricians unlock stronger vaccination rates? 07 October 2026 (Vaccines Today)

Launch first, negotiate later: pharma’s plan to speed up access to medicines 02 October 2026 (EU Perspectives)

Engaging children, adolescents and young adults living with rare diseases as research partners:... 29 September 2026 (Frontiers)

Overcoming barriers between medicines and patients in the UK 22 September 2026 (FT)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶